Study S003310

A Single Dose Pharmacokinetic Study of ray1225 in Subjects With Varying Degrees of Hepatic Impairment

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06577415
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: UNKNOWN
Enrollment: 24
Start: 2024-08-26
Primary completion: 2025-10-31
Lead sponsor: Guangdong Raynovent Biotech Co., Ltd
Conditions: Hepatic Impairment
Interventions: DRUG:RAY1225
Results posted: FALSE

Registered primary outcomes

Pharmacokinetics (PK): Area Under The Drug Concentration-Time Curve From Zero To Infinity (AUC[0-∞]) of RAY1225 [DAY1~43]
PK: Maximum Observed Drug Concentration (Cmax) of RAY1225 [DAY1~43]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.